NCM·Healthcare·$56M·#244 / 520 in Healthcare
IBIO iBio, Inc.
46SPECULATIVE
CATEGORY BREAKDOWN
GROWTH91
QUALITY60
STABILITY36
VALUATION0
GOVERNANCE13
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+77.8%
91
> 50% strong
Gross Margin
Revenue retained after direct costs
541.8%
100
> 50% strong
Cash Runway
Months of cash at current burn rate
7 months
14
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
23.6%
81
< 25% strong
Price / Sales
Market cap relative to trailing revenue
186.1x
0
< 3x strong
Rule of 40
Growth rate plus operating margin
-4573
0
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
2.4%
19
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+259.1%
0
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE IBIO WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when IBIO's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.